Jean-Paul Clozel, Idorsia CEO (Patrick Straub/Keystone via AP Images)
FDA approves potential blockbuster insomnia drug, a first for Swiss biotech Idorsia
The FDA on Monday approved Swiss biotech Idorsia’s first drug, known commercially as Quviviq, for the treatment of adults with insomnia.
The road to approval …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
